PROBLEM TO BE SOLVED: To provide antibodies and compositions for human cancer therapy, e.g. for the treatment of breast cancer, ovarian cancer, gastric cancer and other cancers that overexpress HER2.SOLUTION: The present invention relates to novel therapeutic antibodies directed against HER2 (ErbB2), as well as recombinant polyclonal anti-HER2 antibody compositions comprising at least two of said recombinant anti-HER2 antibodies, and use of the antibodies and antibody compositions for treatment of cancer.SELECTED DRAWING: NoneCOPYRIGHT: (C)2017,JPO&INPIT【課題】 ヒト癌治療、例えば、HER2を過剰発現する乳癌、卵巣癌、胃癌および他の癌の治療のための該抗体および組成物を提供すること。【解決手段】 HER2(ErbB2)に対して向けられた新規な治療用の抗体、同様に少なくとも2つの前記組換え型抗HER2抗体を含む組換え型ポリクローナル抗HER2抗体組成物、並びに癌の処置用の抗体および抗体組成物の使用を提供する。【選択図】なし
